Digital contact-tracing during the Covid-19 pandemic: An analysis of newspaper coverage in Germany, Austria, and Switzerland.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 15 10 2020
accepted: 20 01 2021
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 17 2 2021
Statut: epublish

Résumé

Governments around the globe have started to develop and deploy digital contact tracing apps to gain control over the spread of the novel coronavirus (Covid-19). The appropriateness and usefulness of these technologies as a containment measure have since sparked political and academic discussions globally. The present paper contributes to this debate through an exploration of how the national daily newspapers in Germany, Austria, and Switzerland reported on the development and adoption of digital contact-tracing apps during early and after stages of the lockdown. These countries were among the first in Europe to develop apps and were critical voices in the debate of decentralized vs. centralized data processing. We conducted thematic analysis on news coverage published between January and May 2020 in high-circulation national daily newspapers from Germany, Austria, and Switzerland. A total of 148 articles from nine newspaper companies were included in the final analysis. From our analysis emerged six core themes of the development and adoption of digital contact tracing apps: 1) data governance; 2) role of IT giants; 3) scientific rigor; 4) voluntariness; 5) functional efficacy; 6) role of the app. These results shed light on the different facets of discussion regarding digital contact tracing as portrayed in German-speaking media. This study complements emerging survey data on public perceptions of digital contact tracing apps by providing a better understanding of the ideas circulating in the media ecosystem.

Identifiants

pubmed: 33534839
doi: 10.1371/journal.pone.0246524
pii: PONE-D-20-32473
pmc: PMC7857553
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0246524

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Med. 2020 Apr;26(4):463-464
pubmed: 32284619
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Science. 2020 May 8;368(6491):
pubmed: 32234805
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33037063
Addiction. 2014 Apr;109(4):578-84
pubmed: 24279299
Ethics Inf Technol. 2021;23(Suppl 1):45-57
pubmed: 32837287
JMIR Public Health Surveill. 2020 Sep 1;6(3):e20572
pubmed: 32755882
Front Med (Lausanne). 2020 Jun 05;7:274
pubmed: 32582739
Risk Anal. 2003 Aug;23(4):705-16
pubmed: 12926564
BMJ. 2020 Apr 6;369:m1373
pubmed: 32253180
BMC Med. 2020 Jul 30;18(1):240
pubmed: 32727547
Int J Inf Manage. 2020 Dec;55:102178
pubmed: 32836636
BMC Public Health. 2011 Jul 19;11:575
pubmed: 21771296
J Med Internet Res. 2020 Nov 13;22(11):e22205
pubmed: 33048825
Swiss Med Wkly. 2020 Jul 16;150:w20324
pubmed: 32672340
Nurs Health Sci. 2013 Sep;15(3):398-405
pubmed: 23480423
Tob Control. 2014 Nov;23(6):507-12
pubmed: 23884011
J Glob Health. 2020 Dec;10(2):020103
pubmed: 33110502
Eur J Public Health. 2021 Feb 1;31(1):49-51
pubmed: 33340328
Lancet Digit Health. 2020 Aug;2(8):e425-e434
pubmed: 32835200
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488
Science. 2020 Sep 18;369(6510):1465-1470
pubmed: 32680881

Auteurs

Julia Amann (J)

Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.

Joanna Sleigh (J)

Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.

Effy Vayena (E)

Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH